These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25206483)

  • 1. 8-hydroxy-2-(di-n-propylamino)tetralin intervenes with neural cell apoptosis following diffuse axonal injury.
    Mao Z; Song Z; Li G; Lv W; Zhao X; Li B; Feng X; Chen Y
    Neural Regen Res; 2013 Jan; 8(2):133-42. PubMed ID: 25206483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of 8-OH-DPAT on the rat neuronal apoptosis after diffuse brain injury coupled with secondary brain injury.
    Li B; Song Z; Liang G; Lei W; Wang Z; Liu E; Li X; Liu H
    Pharmazie; 2015 Apr; 70(4):251-5. PubMed ID: 26012255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapeutic efficacy conferred by the 5-HT(1A) receptor agonist 8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) after experimental traumatic brain injury is not mediated by concomitant hypothermia.
    Kline AE; Massucci JL; Dixon CE; Zafonte RD; Bolinger BD
    J Neurotrauma; 2004 Feb; 21(2):175-85. PubMed ID: 15000758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Buspirone, Fluoxetine and 8-OH-DPAT on Striatal Expression of Bax, Caspase-3 and Bcl-2 Proteins in 6-Hydroxydopamine-Induced Hemi-Parkinsonian Rats.
    Sharifi H; Mohajjel Nayebi A; Farajnia S; Haddadi R
    Adv Pharm Bull; 2015 Nov; 5(4):491-5. PubMed ID: 26819921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral cavity absorption of (R)-8-hydroxy-2-(di-n-propylamino)tetralin and (S)-8-acetyl-2-(di-n-propylamino)tetralin in the rat.
    Yu H; Liu Y; Hacksell U; Lewander T
    J Pharm Pharmacol; 1996 Jan; 48(1):41-5. PubMed ID: 8722493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute administration of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), a selective 5-HT-receptor agonist, causes a biphasic blood pressure response and a bradycardia in the normotensive Sprague-Dawley rat and in the spontaneously hypertensive rat.
    Gradin K; Pettersson A; Hedner T; Persson B
    J Neural Transm; 1985; 62(3-4):305-19. PubMed ID: 3161997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis.
    Fozard JR; Mir AK; Middlemiss DN
    J Cardiovasc Pharmacol; 1987 Mar; 9(3):328-47. PubMed ID: 2437400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multiple [3H]8-hydroxy-2-(di-n-propylamino)-tetralin binding sites in rat brain: modulation by GTP and cations].
    Yokota N; Yamawaki S; Hayakawa H; Yoshida R; Sarai K
    Yakubutsu Seishin Kodo; 1989 Jun; 9(2):197-206. PubMed ID: 2530729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic studies of (R)-8-hydroxy-2-(di-n-propylamino)tetralin in the rat.
    Yu H; Lewander T
    Eur Neuropsychopharmacol; 1997 Aug; 7(3):165-72. PubMed ID: 9213074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
    Chaouloff F; Jeanrenaud B
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A competitive interaction model predicts the effect of WAY-100,635 on the time course of R-(+)-8-hydroxy-2-(di-n-propylamino)tetralin-induced hypothermia.
    Zuideveld KP; Treijtel N; Maas HJ; Gubbens-Stibbe JM; Peletier LA; van Der Graaf PH; Danhof M
    J Pharmacol Exp Ther; 2002 Jan; 300(1):330-8. PubMed ID: 11752133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential anxiolytic properties of 8-hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin 1A receptor agonist.
    Carli M; Samanin R
    Psychopharmacology (Berl); 1988; 94(1):84-91. PubMed ID: 2894704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of brain concentrations of 8-hydroxy-2-(di-n-propylamino)tetralin by liquid chromatography with electrochemical detection.
    Perry KW; Fuller RW
    Biochem Pharmacol; 1989 Oct; 38(19):3169-73. PubMed ID: 2530985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-hydroxytryptamine 1A receptor activation protects against N-methyl-D-aspartate-induced apoptotic cell death in striatal and mesencephalic cultures.
    Madhavan L; Freed WJ; Anantharam V; Kanthasamy AG
    J Pharmacol Exp Ther; 2003 Mar; 304(3):913-23. PubMed ID: 12604665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypotensive action of 8-hydroxy-2-(di-N-propylamino)tetralin (8-OH-DPAT) in spontaneously hypertensive rats.
    Martin GE; Lis EV
    Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):251-61. PubMed ID: 3159366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 8-hydroxy-2-(di-N-propylamino)tetralin increases the activity of adenylate cyclase in the hippocampus of freely-moving rats.
    Sijbesma H; Schipper J; Molewijk HE; Bosch AI; de Kloet ER
    Neuropharmacology; 1991 Sep; 30(9):967-75. PubMed ID: 1717874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperinsulinemia of the genetically obese (fa/fa) rat is decreased by a low dose of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
    Chaouloff F; Jeanrenaud B
    Eur J Pharmacol; 1988 Feb; 147(1):111-8. PubMed ID: 2967189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT).
    Dourish CT; Hutson PH; Curzon G
    Brain Res Bull; 1985 Oct; 15(4):377-84. PubMed ID: 2933126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia.
    Bill DJ; Knight M; Forster EA; Fletcher A
    Br J Pharmacol; 1991 Aug; 103(4):1857-64. PubMed ID: 1833017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 8-Hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin1A receptor agonist, reduces the immobility of rats in the forced swimming test by acting on the nucleus raphe dorsalis.
    Cervo L; Grignaschi G; Samanin R
    Eur J Pharmacol; 1988 Dec; 158(1-2):53-9. PubMed ID: 2975608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.